← Back to charts
Opioid Conversion Calculator icon
APP STORE

Opioid Conversion Calculator

Ayrial Beall · Medical · United States store
NOT IN TOP 100 HERE
View on App Store ↗ Instagram card
Revenue a month, worldwide EST
$353
Likely $118 to $1.1K
New ratings
+0
in 3 days, 52 in total
Rating
3.7 of 5
17 ratings in this store
Countries it ranks in
1
was 1 on Oct 19, 2026

Revenue

Estimated from the grossing charts of Oct 26, 2026 in the 53 countries we track, and ratings growth on the App Store.

EST. REVENUE / YEAR · WORLDWIDE
$4.2K
1.2 new ratings a month on average since launch
EST. LIFETIME DOWNLOADS
595 to 1.7K
Estimated from ratings count
WHERE ITS USERS ARE · SHARE OF RATINGS
  • United States 17 ratings33%
  • Germany 10 ratings19%
  • Australia 6 ratings12%
  • Brazil 4 ratings8%
  • France 3 ratings6%
  • Italy 3 ratings6%
  • Canada 2 ratings4%
  • Netherlands 2 ratings4%
HOW SURE ARE WE
Not in any grossing chart, so this comes from ratings growth (1.2 new ratings a month on average since launch): revenue grows with new ratings, more slowly for apps that collect ratings fast. Tested on 418 apps with verified revenue: typically off by about 2 times, and big earners tend to come out low. Countries we don't track (and Google Play in China, which doesn't exist) aren't included, and neither are ads or web payments. Gross revenue before store fees.
RATINGS
17
AVG RATING
3.71
PRICE
Free
AGE
3.6y
LAST UPDATE
30d ago
VERSION
4.0.0
SIZE
76 MB
AGE RATING
17+

Last 30 days

From our daily snapshots of every grossing chart and daily ratings counts.

DAYS IN A GROSSING CHART
16 / 30
COUNTRIES NOW
1 (was 0)
NEW RATINGS, LAST 3 DAYS
+0
EST. REVENUE A MONTH, DAILY · APP STORE EST
Show daily values
Sep 27, 2026not in a grossing chart
Sep 28, 2026not in a grossing chart
Sep 29, 2026not in a grossing chart
Sep 30, 2026not in a grossing chart
Oct 1, 2026not in a grossing chart
Oct 2, 2026not in a grossing chart
Oct 3, 2026not in a grossing chart
Oct 4, 2026not in a grossing chart
Oct 5, 2026not in a grossing chart
Oct 6, 2026$7.1K a month
Oct 7, 2026not in a grossing chart
Oct 8, 2026not in a grossing chart
Oct 9, 2026not in a grossing chart
Oct 10, 2026not in a grossing chart
Oct 11, 2026not in a grossing chart
Oct 12, 2026not in a grossing chart
Oct 13, 2026not in a grossing chart
Oct 14, 2026not in a grossing chart
Oct 15, 2026not in a grossing chart
Oct 16, 2026not in a grossing chart
Oct 17, 2026not in a grossing chart
Oct 18, 2026not in a grossing chart
Oct 19, 2026not in a grossing chart
Oct 20, 2026not in a grossing chart
Oct 21, 2026not in a grossing chart
Oct 22, 2026not in a grossing chart
Oct 23, 2026not in a grossing chart
Oct 24, 2026not in a grossing chart
Oct 25, 2026$1.2K a month
Oct 26, 2026not in a grossing chart
The same estimate as the headline, saved every day. Best rank Sep 27, 2026: not ranked. Now: #62 Medical · AR.
RATINGS IN THE CORE COUNTRIES, DAILY
Show daily values
Oct 23, 202652 ratings
Oct 24, 202652 ratings
Oct 25, 202652 ratings
Oct 26, 202652 ratings
52 on Oct 23, 2026, 52 on Oct 26, 2026. New ratings track new downloads, even outside the charts.

Money and momentum

Measured from the store, not estimated.

WHAT IT CHARGES
3 purchases listed
  • Annual Pro Access$19.99
  • Monthly Pro Access$3.99
  • Lifetime Pro Access$79.99
Top in-app purchases as listed on the App Store, in local prices.
REVIEW MOMENTUM
0.0 reviews / week
  • Recent reviews average1.7 stars
  • Recent 1 and 2 star share67%
From the latest 3 written reviews, covering 1003 days.
RELEASE CADENCE
3 updates in 90 days
  • Typical gap between releases64 days
From the last 11 versions listed on the App Store.
RATING BREAKDOWN
17 ratings
5★65%
4★0%
3★6%
2★0%
1★29%

What users say

Latest reviews, United States App Store.

★★★★★Nov 8, 2025
Criminal Investogator

Yes

★★★★★Sep 12, 2024
In accurate conversions.

I downloaded the app as a alternative to the old CDC guideline app, which is no longer available for download. I ran it through a couple of calculations. It calculated that hydromorphone 4 mg = 20 MME. This is incorrect as the answer should have been 16 MME. Also, oxymorphone is missing from the conversion list. It is still a medication and it does still exist. There should be a tool for calculating its conversion. Very poorly researched, very misleading.

★★★★★Jan 27, 2024
Don’t use

Trash

Apps like this

Same category, earning about as much.

Store screenshots

ScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshot

App Store ads

Apple Search Ads this app ran in the last 90 days, from Apple's public ad repository.

No App Store ads in the EU
None in the last 90 days.

Apple only publishes ads shown in the EU (EU Digital Services Act), with a 7 day delay. An app that advertises only outside the EU shows nothing here.

Growth research

Where this app is buying and earning its users. Each link opens pre filtered.

ASO keywords

Most repeated terms in the listing. Highlighted ones also appear in the title.

dose7clinical6opioid5converted dose5switching timing5conversion4opioids4result4switching4pro4routes oral3oral parenteral3incomplete cross3cross tolerance3products clinical3clinical information3breakthrough dosing3dosing switching3conversion factors3calculator3oral3ome3converted3breakthrough3

What's new in 4.0.0

A cleaner, calmer design with the result first, and new tools for switching opioids. • Dose colour guide. The equivalent header warms from orange at 50 mg/day (CDC 2022) to red at 120 mg/day (Opioids Aware). Move the thresholds or turn it off in Menu › Dose colours, for example for palliative care. • The result comes first. Each result opens with the converted dose, then products, clinical information, breakthrough dosing and switching timing, with the regimen it came from below. • Route conversion. Compare daily doses of the same opioid by different routes, such as oral and parenteral morphine, or oral and IV methadone, with the method and sources shown. Find it in the menu. • Switching timing for everyone. See when to start the new opioid when changing between patches, modified-release opioids and CSCI, straight from the menu. • Methadone, explained. Methadone results show how they were calculated and are clearly marked as not a starting dose. • Works offline from the first launch. A built-in medicine list means the calculator works before the app has connected. • Up-to-date products. Products and strengths are refreshed monthly from official sources, without waiting for an app update. • Clearer capped doses. When a dose is held at a medicine's maximum, the row says what it was capped from, in one calm line. • Easier to read at a glance. Your phone's own system font with aligned figures, and doses without trailing zeros, so 40 can't be misread as 400. • Better on iPad, with a readable column and centred sheets. • Fewer interruptions. Once you accept a dose above the usual maximum, stepping it with + no longer asks again.

Released Apr 5, 2023. Current version shipped Sep 26, 2026.

Store description

Opioid Conversion Calculator is built for health professionals who need a clear, efficient way to compare opioid doses and review the clinical context behind a conversion. Built by a pharmacist. CALCULATE AND COMPARE - Calculate total oral morphine equivalent (OME) across multiple opioids and routes: oral, parenteral, rectal, sublingual and transdermal. - See every converted dose at once, after applying a chosen Target OME percentage for incomplete cross-tolerance. - View conservative, rounded-down target and breakthrough dose suggestions. - See where a daily dose sits: the header warms from orange at 50 mg/day (CDC 2022) to red at 120 mg/day (Opioids Aware). Adjust the thresholds or turn the guide off. - Methadone uses its own dose-dependent model, and its results are clearly marked as not a starting dose. - Convert the same opioid between routes, such as oral and parenteral morphine, with the method and sources shown. EVERY RESULT, IN CONTEXT - Each result opens with the converted dose, then products, clinical information, breakthrough dosing and switching timing. - Read practice points alongside formulation-specific pharmacology, with links to the supporting sources. - Check when to start the new opioid when switching between patches, modified-release opioids and CSCI. Switching timing is also in the menu, free for everyone. - View official products and strengths for Australia, the United States, Germany, France and Spain, chosen independently from the app language. TAILOR THE WORKFLOW - Edit conversion factors and choose which opioids appear, with Pro. - Export and import settings when moving between devices, with Pro. - Works offline, including on first launch. - Use the app in English, French, German, Italian, Portuguese (Brazil) or Spanish. PRO ACCESS The calculator stays free: the combined OME and every converted dose need no account or purchase. Pro adds breakthrough dosing, switching timing, products and clinical information to every result, plus custom conversion factors, opioid visibility and settings transfer. Your first detailed results are free to try. Available plans, prices and any introductory offer are shown using the information supplied by the App Store before purchase. Purchases can be restored in the app. CLINICAL USE Equianalgesic conversions are estimates and do not replace clinical judgement. Consider incomplete cross-tolerance, patient factors, formulation, route, local guidance and monitoring when interpreting a result. Review the references and terms of use before using the calculator in clinical practice. Privacy policy: https://opioidconversioncalculator.com/privacy Terms of use: https://opioidconversioncalculator.com/terms

See this store page in another country

Prices, ranks and reviews are per country. Revenue above is already worldwide.

More from Ayrial Beall

Namely: Baby Names Together
Lifestyle
13 ratingsAnalyze →